Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.420
-0.001 (-0.33%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Xtant Medical Holdings Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Xtant Medical Holdings stock have an average target of 1.25, with a low estimate of 1.00 and a high estimate of 1.50. The average target predicts an increase of 197.55% from the current stock price of 0.42.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Xtant Medical Holdings stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Dec '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $0.95 → $1.5 | Buy | Reiterates | $0.95 → $1.5 | +257.06% | May 14, 2026 |
| BTIG | BTIG | Buy Maintains $1.5 → $1 | Buy | Maintains | $1.5 → $1 | +138.04% | Apr 1, 2026 |
Financial Forecast
Revenue This Year
102.41M
from 133.93M
Decreased by -23.54%
Revenue Next Year
111.99M
from 102.41M
Increased by 9.36%
EPS This Year
-0.08
from 0.04
EPS Next Year
-0.01
from -0.08
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 103.1M | 112.4M | |
| Avg | 102.4M | 112.0M | |
| Low | 102.0M | 111.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -23.0% | 9.8% | |
| Avg | -23.5% | 9.4% | |
| Low | -23.8% | 8.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.08 | -0.01 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.